Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
SEC Accession No. 0001354457-22-000109
Filing Date
2022-02-07
Accepted
2022-02-07 16:24:27
Documents
2
Effectiveness Date
2022-02-07

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 25-NSE  
1 primary_doc.xml 25-NSE 1096
2 amgn22-form25.txt EX-99.25 119
  Complete submission text file 0001354457-22-000109.txt   3013
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Subject) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE | Act: 34 | File No.: 000-12477 | Film No.: 22597688
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address Office of General Counsel 805 King Farm Blvd. ROCKVILLE MD 20850
Business Address One Liberty Plaza New York NY 10006 301-978-4144
Nasdaq Stock Market LLC (Filed by) CIK: 0001354457 (see all company filings)

EIN.: 521165937 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE